Format

Send to

Choose Destination
Antibiotics (Basel). 2019 May 30;8(2). pii: E72. doi: 10.3390/antibiotics8020072.

Disulfiram (Tetraethylthiuram Disulfide) in the Treatment of Lyme Disease and Babesiosis: Report of Experience in Three Cases.

Author information

1
592 Route 22-Suite 1B, Pawling, NY 12564, USA. kbliegnermd@optonline.net.
2
Northwell System, Northern Westchester Hospital, Mount Kisco, NY 10549, USA. kbliegnermd@optonline.net.
3
Health Quest System, Sharon Hospital, Sharon, CT 06069, USA. kbliegnermd@optonline.net.

Abstract

Three patients, each of whom had required intensive open-ended antimicrobial therapy for control of the symptoms of chronic relapsing neurological Lyme disease and relapsing babesiosis, were able to discontinue treatment and remain clinically well for periods of observation of 6-23 months following the completion of a finite course of treatment solely with disulfiram. One patient relapsed at six months and is being re-treated with disulfiram.

KEYWORDS:

Chronic Lyme disease; Post-treatment Lyme disease syndrome (PTLDS); antibiotic treatment failure; disulfiram; neuroborreliosis; persistent infection; relapsing babesiosis

PMID:
31151194
DOI:
10.3390/antibiotics8020072
Free full text

Supplemental Content

Full text links

Icon for Multidisciplinary Digital Publishing Institute (MDPI)
Loading ...
Support Center